Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and...
-
Upload
abigayle-watts -
Category
Documents
-
view
225 -
download
0
Transcript of Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and...
![Page 1: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/1.jpg)
Rotavirus Vaccine:
use in Wisconsin,effects on primary care
visits,
hospitalizations, and laboratory
detectionsJonathan L. Temte, MD/PhD
Associate Professor of Family Medicine & Advisory Committee on Immunization Practices
Stephanie L. Schauer, Richard T. Heffernan, Jeffrey P. DavisWisconsin Division of Public Health
Carol J. Kirk, Peter A. ShultWisconsin State Laboratory of Hygiene
Thomas R. MaerzWisconsin Immunization Registry
![Page 2: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/2.jpg)
“my bowels are troubled, my liver is
poured upon the earth "
Lamentations 2:11
![Page 3: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/3.jpg)
Rotavirus The most common cause
of severe diarrhea among children
Results in hospitalization of approximately 55,000 children each year in the United States
Causes the death of over 600,000 children annually worldwide…
Vaccines that become routine in the U.S. become cheap in the developing world
![Page 4: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/4.jpg)
RotaShieldLicensed
8-31-1998
RotaShiedWithdrawn
October 1999
RotaTeqLicensed
February 2006
ACIP Recommendation
June 2006
Wisconsin VFCDistribution
September 2006
RotavirusVaccineTimeline
![Page 5: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/5.jpg)
Study Objective and Approaches Objectives: Assess the uptake of this vaccine
and evaluate correlates of effectiveness on rotavirus morbidity within one state
Design: Secondary data analysis of existing data sets
Setting: Wisconsin from January 2002 through December 2008
Participants: Anonymous patient interactions as extracted from the Wisconsin Immunization Registry, hospital discharge diagnosis surveillance, a network of 27 specimen testing sites, and a primary care clinical data warehouse
![Page 6: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/6.jpg)
Data Sources Wisconsin Immunization Registry UW- Department of Family Medicine’s
Clinical Data Warehouse Wisconsin State Laboratory of Hygiene
Network of virus labs Passive surveillance of rotavirus
Wisconsin Department of Health and Family Services Hospital discharge diagnosis reporting
![Page 7: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/7.jpg)
Wisconsin Immunization Registry (WIR) Computerized Internet database application Records and tracks immunization dates of
Wisconsin's children and adults Tool for assuring that children and adults:
receive immunizations according to recommended schedules
prevent over-immunizing 1,100 immunization providers and 2,650
schools 27 million immunizations 3.7 million clients
![Page 8: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/8.jpg)
0
500
1000
1500
2000
2500
3000
3500
1/7/2
006
4/7/2
006
7/7/2
006
10/7/
2006
1/7/2
007
4/7/2
007
7/7/2
007
10/7/
2007
1/7/2
008
4/7/2
008
Week
Do
se
s o
f R
ota
Te
qUse of RotaTeqWisconsin birth cohort = 67,000
~ 3800 doses per week to provide 100% coverage
~ 63% Coverageby late 2007
![Page 9: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/9.jpg)
Clinical Data Warehouse
Existing warehouse of patient data Demographic information ICD-9 codes CPT codes EPIC EMR Data
Extensive universe of Primary Care data Approximately 176,624 unique patients
3.2% of Wisconsin’s total population Approximately 312,663 visits per year
Easily accessible for queries
![Page 10: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/10.jpg)
All Ages
0.00
5.00
10.00
15.00
20.00
25.00
30.00
0 52.15 104.3 156.45 208.6 260.75 312.9
Week Number
AD
I Vis
its
per
100
0
DFM Acute Diarrheal IllnessRate of ADI Visits per 1000 per week (2001-2008) (denominator =
2.5 million visits)
Focus on 2006-2008
![Page 11: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/11.jpg)
all ages
y = -0.0116x + 20.792R2 = 0.0539
0.00
5.00
10.00
15.00
20.00
25.00
209 261.15 313.3 365.45
Week Number
AD
I Vis
its
per
100
0
<1 year
y = -0.0032x + 1.6376R2 = 0.1334
0.00
0.50
1.00
1.50
2.00
2.50
3.00
209 261.15 313.3 365.45
Week Number
AD
I Vis
its
per
100
0
1-4 years
y = -0.0019x + 1.5946R2 = 0.0327
0.00
0.50
1.00
1.50
2.00
2.50
209 261.15 313.3 365.45
Week Number
AD
I Vis
its
per
100
0
Slight decline in total visits for ADI
50% decline in ADI visits for <1 year old children
25% decline in ADI visits for 1-4 year old children
![Page 12: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/12.jpg)
5-24 years
y = -0.0006x + 2.8975R2 = 0.0015
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
4.50
5.00
209 261.15 313.3 365.45
Week Number
AD
I Vis
its
per
100
0
25-64 years
y = -0.0002x + 9.555R2 = 5E-05
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
209 261.15 313.3 365.45
Week Number
AD
I Vis
its
per
100
0
65+ years
y = -0.0057x + 5.1075R2 = 0.099
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
209 261.15 313.3 365.45
Week Number
AD
I Vis
its
per
100
0 No change
in ADI visits for patients 5–24 years
No change in ADI visits for patients 25-64 years
25% decline in ADI visits for 65+year old adults
![Page 13: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/13.jpg)
Wisconsin State Laboratory of Hygiene Coordinates the Wisconsin Clinical Laboratory
Network in the state to ensure timely and effective response to clinical laboratory and public health needs emergency preparedness disease surveillance laboratory diagnostics training and education communications
Laboratory Surveillance Reports webpage access to the current laboratory-based surveillance reports
and graphs generated as a testing reports provided by Wisconsin laboratories
current and historical graphs
![Page 14: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/14.jpg)
2004-2005
![Page 15: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/15.jpg)
2005-2006
![Page 16: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/16.jpg)
2006-2007
![Page 17: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/17.jpg)
2007-2008
![Page 18: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/18.jpg)
2008-2009
![Page 19: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/19.jpg)
Wisconsin Department of Health and Family Services
![Page 20: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/20.jpg)
0
10
20
30
40
50
60
70
80
90
Jan-
00
Mar
-00
Jun-
00
Aug
-00
Nov
-00
Jan-
01
Apr
-01
Jun-
01
Sep
-01
Nov
-01
Feb
-02
Apr
-02
Jul-0
2
Sep
-02
Dec
-02
Mar
-03
May
-03
Aug
-03
Oct
-03
Jan-
04
Mar
-04
Jun-
04
Aug
-04
Nov
-04
Jan-
05
Apr
-05
Jun-
05
Sep
-05
Nov
-05
Feb
-06
Apr
-06
Jul-0
6
Sep
-06
Dec
-06
Mar
-07
May
-07
Aug
-07
Oct
-07
Jan-
08
Mar
-08
Jun-
08
Week of admission
Nu
mb
er o
f h
osp
ital
izat
ion
s
0
500
1000
1500
2000
2500
3000
3500
Weekly Rotavirus HospitalizationsWisconsin 2000–2008
2001 2002 2003 2004 2005 2006 2007 2008
Vaccineuptake
84% decline in Rotavirus Hospitalizations
![Page 21: Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.](https://reader035.fdocuments.us/reader035/viewer/2022062221/56649eda5503460f94be8a50/html5/thumbnails/21.jpg)
Conclusions Implementation of an immunization policy
resulted in rapid uptake of vaccine There is evidence for overall reduction in
target syndrome in target population Vaccine use is correlated with rapid
declines in detections of rotavirus Hospitalizations from the pathogen have
rapidly and significantly declined There is evidence for effects of herd
immunity